サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：動物用狂犬病ワクチンの世界市場 - 市場シェア、規模、動向、業界分析：用途別、地域別、セグメント予測（2023年～2032年）
市場調査レポート
商品コード
1219515

動物用狂犬病ワクチンの世界市場 - 市場シェア、規模、動向、業界分析：用途別、地域別、セグメント予測（2023年～2032年）

Rabies Veterinary Vaccines Market Share, Size, Trends, Industry Analysis Report, By Application (Companion Animals, Livestock Animals, Wildlife Animals); By Region; Segment Forecast, 2023 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
動物用狂犬病ワクチンの世界市場 - 市場シェア、規模、動向、業界分析：用途別、地域別、セグメント予測（2023年～2032年）
出版日: 2023年01月01日
発行: Polaris Market Research
ページ情報: 英文 115 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の動物用狂犬病ワクチンの市場規模は、2032年までに8億9,046万米ドルに達すると予測されています。

当レポートでは、世界の動物用狂犬病ワクチン市場について調査分析し、現在の市場力学の考察や、将来の市場成長についての分析などを提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の動物用狂犬病ワクチン市場の考察

  • 動物用狂犬病ワクチン市場 - 業界のスナップショット
  • 動物用狂犬病ワクチンの市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターのファイブフォース分析
  • PESTLE分析
  • バリューチェーン分析
  • 動物用狂犬病ワクチン業界の動向
  • COVID-19の影響の分析

第5章 世界の動物用狂犬病ワクチン市場：用途別

  • 主な調査結果
  • イントロダクション
    • 世界の動物用狂犬病ワクチン：用途別（2019年～2032年）
  • コンパニオンアニマル
  • 家畜
  • 野生動物

第6章 世界の動物用狂犬病ワクチン市場：地域別

  • 主な調査結果
  • イントロダクション
    • 動物用狂犬病ワクチン市場の評価：地域別（2019年～2032年）
  • 動物用狂犬病ワクチン市場 - 北米
    • 北米の動物用狂犬病ワクチン市場：用途別（2019年～2032年）
    • 動物用狂犬病ワクチン市場 - 米国
    • 動物用狂犬病ワクチン市場 - カナダ
  • 動物用狂犬病ワクチン市場 - 欧州
    • 欧州の動物用狂犬病ワクチン市場：用途別（2019年～2032年）
    • 動物用狂犬病ワクチン市場 - 英国
    • 動物用狂犬病ワクチン市場 - フランス
    • 動物用狂犬病ワクチン市場 - ドイツ
    • 動物用狂犬病ワクチン市場 - イタリア
    • 動物用狂犬病ワクチン市場 - スペイン
    • 動物用狂犬病ワクチン市場 - オランダ
    • 動物用狂犬病ワクチン市場 - ロシア
  • 動物用狂犬病ワクチン市場 - アジア太平洋
    • アジア太平洋の動物用狂犬病ワクチン市場：用途別（2019年～2032年）
    • 動物用狂犬病ワクチン市場 - 中国
    • 動物用狂犬病ワクチン市場 - インド
    • 動物用狂犬病ワクチン市場 - マレーシア
    • 動物用狂犬病ワクチン市場 - 日本
    • 動物用狂犬病ワクチン市場 - インドネシア
    • 動物用狂犬病ワクチン市場 - 韓国
  • 動物用狂犬病ワクチン市場 - 中東・アフリカ
    • 中東・アフリカの動物用狂犬病ワクチン市場：用途別（2019年～2032年）
    • 動物用狂犬病ワクチン市場 - サウジアラビア
    • 動物用狂犬病ワクチン市場 - アラブ首長国連邦
    • 動物用狂犬病ワクチン市場 - イスラエル
    • 動物用狂犬病ワクチン市場 - 南アフリカ
  • 動物用狂犬病ワクチン市場 - ラテンアメリカ
    • ラテンアメリカの動物用狂犬病ワクチン市場：用途別（2019年～2032年）
    • 動物用狂犬病ワクチン市場 - メキシコ
    • 動物用狂犬病ワクチン市場 - ブラジル
    • 動物用狂犬病ワクチン市場 - アルゼンチン

第7章 競合情勢

  • 拡張と買収の分析
    • 拡張
    • 買収
  • パートナーシップ/提携/協定/公開

第8章 企業プロファイル

  • Merck & Co. (MSD Animal Health)
  • Indian Immunologicals Ltd
  • Novartis AG
  • Pfizer Inc
  • Sanofi SA
  • Boehringer Ingelheim International GmbH (Animal Health)
  • BroadChem Philippines Biopharma Corporation
  • Berna Biotech Ltd
  • Elanco
  • Ceva
  • BiogenesisBago
  • Bharat Biotech
  • GlaxoSmithKline plc
図表

List of Tables

  • Table 1 Global Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 2 Global Rabies Veterinary Vaccines Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 3 North America: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 4 U.S.: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 5 Canada: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 6 Canada: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 7 Europe: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 8 Spain: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 9 Netherlands: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 10 Russia: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 11 Germany: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 12 Italy: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 13 France: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 14 Asia Pacific: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 15 China: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 16 Japan: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 17 India: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 18 Indonesia: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 19 South Korea: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 20 Malaysia: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 21 Latin America: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 22 Brazil: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 23 Mexico: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 24 Argentina: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 25 Middle East & Africa: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 26 South Africa: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 27 Israel: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 28 Saudi Arabia: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • Table 29 UAE: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)

List of Figures

Figure 1 Global Rabies Veterinary Vaccines Market, 2019-2032 (USD Million)

Figure 2 Integrated Ecosystem

Figure 3 Research Methodology: Top-Down & Bottom-Up Approach

Figure 4 Market by Geography

Figure 5 Porter's Five Forces

Figure 6 Market by Application

Figure 7 Global Rabies Veterinary Vaccines Market, by Application, 2021 & 2030 (USD Million)

Figure 8 Rabies Veterinary Vaccines Market Assessment, By Geography, 2019-2032 (USD Million)

Figure 9 Strategic Analysis - Rabies Veterinary Vaccines Market

目次
Product Code: PM2968

The global rabies veterinary vaccines market size is expected to reach USD 890.46 million by 2032, according to a new study by Polaris Market Research. The report "Rabies Veterinary Vaccines Market Share, Size, Trends, Industry Analysis Report, By Application (Companion Animals, Livestock Animals, Wildlife Animals); By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of rabies all over the world is expected to become a major driving force for the market over the forecast period, increasing no of infections from animals resulting in human mortality helps in the growth of the market. Adoption is higher in North America as compared to other nations. This is because of the large pet population, & expensive veterinary healthcare expenditures. Additionally, the high annual public health expenditures in these regions to eradicate rabies virus helps in the growth of the market.

According to the Centers for Disease Control and Prevention (CDC), within 28 days of the first vaccine. If the original vaccine was given at least 28 days ago or booster vaccinations were given in line with instructions, an animal is considered presently vaccinated and immunized. Because a quick anamnestic reaction is predicted, an animal is deemed presently immunized immediately following booster immunization.

As per WHO, rabies veterinary vaccines may be divided into several vaccines based on whether they are live or inactivated and depending on the properties of the cell substrate that is utilized for viral replication. According to vaccination properties, these vaccines are manufactured for delivery to domestic animals or wild species via parenteral or oral methods. In both Europe and the USA, oral rabies vaccinations are often administered to foxes and raccoons. In developing countries, trials for oral dog immunization are underway.

As a part of the rabies control strategy, WOAH collaborates with the World Health Organization (WHO), the Food and Agriculture Organization of the United Nations (FAO), and the Global Alliance for Rabies Control (GARC) to develop on international recommendations aimed to eradicate rabies, by 2030. Rabies Veterinary Vaccines are widely used in pets and livestock animals as the virus can easily affect humans. Some nations have already eliminated rabies through strong preventative measures, while the disease still exists in others, mostly harming wild host animals.

Rabies Veterinary Vaccines Market Report Highlights

  • Companion animals segment is projected to grow at a significant rate over the study period, owing to the increasing percentages of homes owning dogs or cats also strict regulation for animal vaccination boosts the market growth.
  • Wildlife Animal segment sector is expected to hold a significant market share over the forecast period due to the increase in the number of people infected with this virus as a result of encounters with animals will favor market expansion.
  • North America is expected to grow at a considerable CAGR \over the projected period on account of the increasing pet population and high veterinary healthcare costs. Moreover, the use of mass vaccination programs by government organizations in that region increases market growth.
  • The global players include: Merck, Indian Immunologicals, Novartis, Pfizer Inc, Sanofi, Boehringer Ingelheim, BroadChem Philippines Biopharma Corporation, Berna Biotech, Elanco, Ceva, Biogenesis Bago, Bharat Biotech, and GlaxoSmithKline.

Polaris Market Research has segmented the Rabies Veterinary Vaccines market report based on application and region:

Rabies Veterinary Vaccines, Application Outlook (Revenue - USD Million, 2019-2032)

  • Companion Animals
  • Livestock Animals
  • Wildlife Animals

Rabies Veterinary Vaccines, Regional Outlook (Revenue - USD Million, 2019-2032)

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Rabies Veterinary Vaccines Market Insights

  • 4.1. Rabies Veterinary Vaccines Market - Industry Snapshot
  • 4.2. Rabies Veterinary Vaccines Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising cases of rabies infection in people
      • 4.2.1.2. increasing government initiatives to contain the virus
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High storage costs of vaccines
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Value Chain Analysis
  • 4.6. Rabies Veterinary Vaccines Industry trends
  • 4.7. COVID-19 Impact Analysis

5. Global Rabies Veterinary Vaccines Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Rabies Veterinary Vaccines, by Application, 2019-2032 (USD Million)
  • 5.3. Companion Animals
    • 5.3.1. Global Rabies Veterinary Vaccines Market, by Companion Animals, by Region, 2019-2032 (USD Million)
  • 5.4. Livestock Animals
    • 5.4.1. Global Rabies Veterinary Vaccines Market, by Livestock Animals, by Region, 2019-2032 (USD Million)
      • 5.4.1.1.
  • 5.5. Wildlife Animals
    • 5.5.1. Global Rabies Veterinary Vaccines Market, by Wildlife Animals, by Region, 2019-2032 (USD Million)

6. Global Rabies Veterinary Vaccines Market, by Geography

  • 6.1. Key findings
  • 6.2. Introduction
    • 6.2.1. Rabies Veterinary Vaccines Market Assessment, By Geography, 2019-2032 (USD Million)
  • 6.3. Rabies Veterinary Vaccines Market - North America
    • 6.3.1. North America: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.3.2. Rabies Veterinary Vaccines Market - U.S.
      • 6.3.2.1. U.S.: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.3.3. Rabies Veterinary Vaccines Market - Canada
      • 6.3.3.1. Canada: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • 6.4. Rabies Veterinary Vaccines Market - Europe
    • 6.4.1. Europe: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.4.2. Rabies Veterinary Vaccines Market - UK
      • 6.4.2.1. UK: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.4.3. Rabies Veterinary Vaccines Market - France
      • 6.4.3.1. France: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.4.4. Rabies Veterinary Vaccines Market - Germany
      • 6.4.4.1. Germany: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.4.5. Rabies Veterinary Vaccines Market - Italy
      • 6.4.5.1. Italy: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.4.6. Rabies Veterinary Vaccines Market - Spain
      • 6.4.6.1. Spain: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.4.7. Rabies Veterinary Vaccines Market - Netherlands
      • 6.4.7.1. Netherlands: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.4.8. Rabies Veterinary Vaccines Market - Russia
      • 6.4.8.1. Russia: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • 6.5. Rabies Veterinary Vaccines Market - Asia Pacific
    • 6.5.1. Asia Pacific: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.5.2. Rabies Veterinary Vaccines Market - China
      • 6.5.2.1. China: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.5.3. Rabies Veterinary Vaccines Market - India
      • 6.5.3.1. India: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.5.4. Rabies Veterinary Vaccines Market - Malaysia
      • 6.5.4.1. Malaysia: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.5.5. Rabies Veterinary Vaccines Market - Japan
      • 6.5.5.1. Japan: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.5.6. Rabies Veterinary Vaccines Market - Indonesia
      • 6.5.6.1. Indonesia: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.5.7. Rabies Veterinary Vaccines Market - South Korea
      • 6.5.7.1. South Korea: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • 6.6. Rabies Veterinary Vaccines Market - Middle East & Africa
    • 6.6.1. Middle East & Africa: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.6.2. Rabies Veterinary Vaccines Market - Saudi Arabia
      • 6.6.2.1. Saudi Arabia: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.6.3. Rabies Veterinary Vaccines Market - UAE
      • 6.6.3.1. UAE: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.6.4. Rabies Veterinary Vaccines Market - Israel
      • 6.6.4.1. Israel: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.6.5. Rabies Veterinary Vaccines Market - South Africa
      • 6.6.5.1. South Africa: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
  • 6.7. Rabies Veterinary Vaccines Market - Latin America
    • 6.7.1. Latin America: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.7.2. Rabies Veterinary Vaccines Market - Mexico
      • 6.7.2.1. Mexico: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.7.3. Rabies Veterinary Vaccines Market - Brazil
      • 6.7.3.1. Brazil: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)
    • 6.7.4. Rabies Veterinary Vaccines Market - Argentina
      • 6.7.4.1. Argentina: Rabies Veterinary Vaccines Market, by Application, 2019-2032 (USD Million)

7. Competitive Landscape

  • 7.1. Expansion and Acquisition Analysis
    • 7.1.1. Expansion
    • 7.1.2. Acquisitions
  • 7.2. Partnerships/Collaborations/Agreements/Exhibitions

8. Company Profiles

  • 8.1. Merck & Co. (MSD Animal Health)
    • 8.1.1. Company Overview
    • 8.1.2. Financial Performance
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Development
  • 8.2. Indian Immunologicals Ltd
    • 8.2.1. Company Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Development
  • 8.3. Novartis AG
    • 8.3.1. Company Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Development
  • 8.4. Pfizer Inc
    • 8.4.1. Company Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Development
  • 8.5. Sanofi SA
    • 8.5.1. Company Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Development
  • 8.6. Boehringer Ingelheim International GmbH (Animal Health)
    • 8.6.1. Company Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Development
  • 8.7. BroadChem Philippines Biopharma Corporation
    • 8.7.1. Company Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Development
  • 8.8. Berna Biotech Ltd
    • 8.8.1. Company Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Development
  • 8.9. Elanco
    • 8.9.1. Company Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Development
  • 8.10. Ceva
    • 8.10.1. Company Overview
    • 8.10.2. Financial Performance
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Development
  • 8.11. BiogenesisBago
    • 8.11.1. Company Overview
    • 8.11.2. Financial Performance
    • 8.11.3. Product Benchmarking
    • 8.11.4. Recent Development
  • 8.12. Bharat Biotech
    • 8.12.1. Company Overview
    • 8.12.2. Financial Performance
    • 8.12.3. Product Benchmarking
    • 8.12.4. Recent Development
  • 8.13. GlaxoSmithKline plc
    • 8.13.1. Company Overview
    • 8.13.2. Financial Performance
    • 8.13.3. Product Benchmarking
    • 8.13.4. Recent Development